Myron Kaplan - Feb 22, 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Myron Kaplan
Stock symbol
CRMD
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:16 PM
Previous filing
Dec 29, 2021
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 155K Feb 22, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20K $0.00 20K Feb 22, 2022 Common Stock 20K $4.03 Direct F7
holding CRMD Stock Option (Right to Buy Common Stock) 30K Feb 22, 2022 Common Stock 30K $8.32 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 15K Feb 22, 2022 Common Stock 15K $5.63 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15K Feb 22, 2022 Common Stock 15K $8.30 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 8K Feb 22, 2022 Common Stock 8K $2.85 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 8K Feb 22, 2022 Common Stock 8K $11.20 Direct F5
holding CRMD Stock Option (Right to Buy Common Stock) 10K Feb 22, 2022 Common Stock 10K $21.40 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/11/2021. These options are fully vested.
F2 These options were granted on 02/25/2020. These options are fully vested.
F3 These options were granted on 01/10/2019. These options are fully vested.
F4 These options were granted on 02/16/2018. These options are fully vested.
F5 These options were granted on 02/21/2017. These options are fully vested.
F6 These options were granted on 4/28/2016. These options are fully vested.
F7 These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.